Logo
x

Search

Subscribe Now

FibroGen

FibroGen Collaborates with Regeneron to Assess FG-3165 and FG-3175 Plus Libtayo for Treating Solid Tumors

FibroGen Collaborates with Regeneron to Assess FG-3165 and FG-3175 Plus Libtayo for Treating Solid Tumors

  • June 4, 2024
FibroGen’s Pamrevlumab Failed to Meet its Primary Endpoints in P-III Trial (LELANTOS-1) for the Treatment of Duchenne Muscular Dystrophy

FibroGen’s Pamrevlumab Failed to Meet its Primary Endpoints in P-III Trial (LELANTOS-1) for the Treatment of Duchenne Muscular Dys...

  • June 8, 2023
PharmaShots Weekly Snapshots (August 16 - 20, 2021)

PharmaShots Weekly Snapshots (August 16 - 20, 2021)

  • August 20, 2021
Astellas and FibroGen's Evrenzo (roxadustat) Receive EC's Approval for Symptomatic Anemia Associated with Chronic Kidney Disease

Astellas and FibroGen's Evrenzo (roxadustat) Receive EC's Approval for Symptomatic Anemia Associated with Chronic Kidney Disease

  • August 20, 2021
PharmaShots Weekly Snapshots (August 09, 13, 2021)

PharmaShots Weekly Snapshots (August 09, 13, 2021)

  • August 13, 2021
PharmaShots Weekly Snapshots (June 21 - 25, 2021)

PharmaShots Weekly Snapshots (June 21 - 25, 2021)

  • June 25, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.